Christophe Massard

17PUBLICATIONS
200CO-AUTHORS
Predictive and prognostic markersHaematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC).

|Apr 01, 2025
Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry.

Thomas Hueso, Justin Cagnat, Kaïssa Ouali

|Feb 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting.

Levon Demirdjian, Spyros Triantos, Kristopher Standish

|Feb 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.

Lillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez

|Jan 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials.

Jia Liu, Max Farrow, Lesley Seymour

|May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.

Julieta Rodriguez, Capucine Baldini, Arnaud Bayle

Pageof 3

Frequent Collaborators

6 joint publications

Benjamin Besse

4 joint publications

Antoine Hollebecque

4 joint publications

Ludovic Lacroix

3 joint publications

Aurelien Marabelle